Labosud

What Labosud does

Labosud (legally SELAS INOVIE LABOSUD) is a multi-site medical biology laboratory group headquartered in Montpellier, France, founded in 2009 by independent medical biologists (physicians and pharmacists) seeking to preserve clinical independence. The group operates a regional network of approximately 100 proximity laboratories across southern France, organized around three major technical platforms in Béziers, Nîmes, and Montpellier and supported by approximately ten emergency technical platforms. With more than 1,000 employees working alongside 100 associated medical biologists, Labosud serves roughly 15,000 patients daily, participates in over 70% of medical diagnoses in its service region, and provides routine testing, specialized biology activities, COVID-19 testing, and 24/7 emergency care.

Name

Labosud

Legal name

SELAS INOVIE LABOSUD

Website

https://labosud.fr

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Labosud (INOVIE Labosud) is a multi-site medical biology laboratory group operating approximately 100 proximity labs across southern France, serving ~15,000 patients daily with diagnostic testing, 24/7 emergency services, and integration with France's national health platform.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Medical laboratory services
• Clinical diagnostics
• Biology testing
• Laboratory network
• Patient diagnostics

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Medical Laboratory Testing Services: INOVIE Labosud generates revenue through medical biology testing services provided to patients and healthcare professionals. The company operates nearly 100 laboratory sites and serves approximately 15,000 patients daily, participating in over 70% of medical diagnoses in their service area.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

INOVIE Labosud operates a network of nearly 100 proximity medical biology laboratories across southern France, serving approximately 15,000 patients daily. The group is organized around three major technical platforms in Béziers, Nîmes, and Montpellier, supported by approximately ten emergency technical platforms, providing routine and specialized diagnostic testing services 24/7 with rapid turnaround. The company participates in more than 70% of medical diagnoses in its service region.

Product overview

INOVIE Labosud is a multi-site medical biology laboratory group founded in 2009, operating as one of the largest laboratory networks in France with approximately 100 proximity laboratories serving over 15,000 patients daily. The organization operates through a hub-and-spoke model: three major technical platforms (plateaux techniques) in Béziers, Nîmes, and Montpellier serve as centralized hubs, supported by approximately ten emergency technical platforms, while the network of proximity laboratories provides distributed patient access. Core services include comprehensive medical biology testing, specialized activities, and COVID-19 testing, delivered by over 1,000 employees working alongside 100 associated medical biologists. The group provides 24/7 urgent care availability and participates in over 70% of regional medical diagnoses.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Biology Laboratory Services Comprehensive medical biology testing services delivered through nearly 100 proximity laboratories across southern France, serving approximately 15,000 patients daily and participating in over 70% of regional medical diagnoses. Includes routine blood tests, diagnostics, and 24/7 emergency services.
• Technical Platforms (Plateaux Techniques) Centralized advanced analysis infrastructure comprising three major technical platforms in Béziers, Nîmes, and Montpellier, supported by approximately ten emergency technical platforms, providing 24/7 urgent care support and advanced diagnostic capabilities.
• Specialized Medical Biology Activities Advanced diagnostic services beyond routine testing, offered at select laboratory sites within the network, providing specialized biology activities for complex diagnostic needs.
• Medical Biology Consultation Services Access to over 100 associated medical biologists (physicians and pharmacists) providing medical expertise, consultation, and diagnostic interpretation across the laboratory network.
• COVID-19 Testing Services Dedicated COVID-19 testing services offered across the laboratory network, with dedicated information resources and testing facilities available at laboratory locations.

Quantifiable outcome

• Serves approximately 15,000 patients daily across nearly 100 laboratory locations
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Exalab: Regional French medical biology laboratory group operating multi-site routine and specialized testing, competing for prescribers and patients in overlapping French regions.
• Cerba Healthcare: French-headquartered medical biology network with routine and specialized diagnostics across multiple sites; competes with Labosud for prescribers, patients, and acquisitions in France.
• Cerballiance: French multi-site medical laboratory network offering routine and specialized diagnostics, directly comparable to Labosud's proximity-lab and technical-platform model.
• Biogroup: One of the largest multi-site medical biology laboratory networks in France, directly comparable to Labosud in routine diagnostics, proximity-lab model, and regional coverage.
• Eurofins Biomnis: French specialty medical laboratory within the Eurofins network, focused on specialized medical biology; overlaps with Labosud's specialized activities and serves similar prescribers.
• Synlab: Major European medical diagnostics provider with a French multi-site lab footprint, competing with Labosud in routine medical biology and reference testing.
• Unilabs: European medical diagnostics network with significant French operations, offering routine and specialty lab services to patients and healthcare professionals; directly comparable business model and customer set.

Broad incumbents

• Quest Diagnostics: Large diversified clinical laboratory network; comparable to Labosud in routine medical biology and lab-network operations, though at much greater scale and geographic breadth.
• Mayo Clinic Laboratories: Global reference laboratory offering a broad menu of specialized and routine diagnostics; comparable to Labosud in the specialized and central-lab capabilities of its three major technical platforms.

Emerging players

• Laborizon: French medical biology network with a multi-site model and similar routine diagnostics offering, comparable in scale-up trajectory to Labosud in certain French regions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/groupe-inovie

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labosud